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Abstract
Background: Rice prolamin has been reported to possess antioxidative, anti-inflammatory and immune-promoting
properties. This study is aimed to examine the protective effects of dietary rice prolamin extract (RPE) against
dinitrochlorobenzene (DNCB)-induced atopic dermatitis (AD)-like skin lesions in mice.
Methods: BALB/c mice were fed diet supplemented with 0–0.1 % RPE for 6 weeks. For the last 2 weeks, 1 % or 0.2 %
DNCB was applied repeatedly to the back skin of mice to induce AD-like lesions. Following AD induction, the severity
of skin lesions was examined macroscopically and histologically. In addition, the serum levels of IgE, IgG1 and IgG2a
were determined by ELISA, and the mRNA expression of IL-4 and IFN-γ in the skin was determined by real-time PCR.
Results: Dietary RPE suppressed the clinical symptoms of DNCB-induced dermatitis as well as its associated
histopathological changes such as epidermal hyperplasia and infiltration of mast cells and eosinophils in the dermis.
RPE treatment also suppressed the DNCB-induced increase in transepidermal water loss. Dietary RPE inhibited the
DNCB-induced enhancement of serum IgE and IgG1 levels, whereas it increased the serum IgG2a level in DNCB-treated
mice. In addition, dietary RPE upregulated the IFN-γ mRNA expression and downregulated the IL-4 mRNA expression in
the skin of DNCB-treated mice.
Conclusions: The above results suggest that dietary RPE exerts a protective effect against DNCB-induced AD in mice
via upregulation of Th1 immunity and that RPE may be useful for the treatment of AD.
Keywords: Dietary rice prolamin extract, Atopic dermatitis, Interferon-gamma
Background
AD is a chronic inflammatory skin disease that often be-
gins in infancy. It causes enormous physical discomfort
and imposes huge demands on time and resources [1].
AD is characterized by pruritus and eczematous skin le-
sions, elevated serum immunoglobulin (Ig) E level, and
infiltration of immune cells such as mast cells, eosino-
phils and lymphocytes in the skin [2, 3]. Th2 cells play a
key role in the pathogenesis of AD [4, 5]. They
synthesize high levels of IL-4 and other Th2 cytokines,
which lead to immunoglobulinemia E, eosinophilia,
epidermal thickening and other AD-associated inflam-
matory changes. Conversely, Th1 cells suppress the Th2
immune responses through production of IFN-γ [6].
Therefore, promotion of Th1 immunity and suppression
of Th2 immunity can be an effective therapeutic meas-
ure for AD [6, 7]. In fact, some strains of probiotic bac-
teria have been reported to exert beneficial effects in
AD by promoting IFN-γ production [8–11].
Rice is a staple food worldwide [12]. In addition, rice
has been described to have various pharmacological and
biological activities including hypocholesterolemic and
anticarcinogenic effects [13–20]. Rice proteins are nutri-
tious for humans with hypoallergenic properties among
the cereal proteins. They consist of four important frac-
tions, identified by differential solubility: water-soluble
albumin, salt-soluble globulin, alkali-soluble glutelin and
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alcohol-soluble prolamin [12, 21]. Recently, antioxidative
[22], anti-inflammatory [23] and immune-promoting [24]
activities of rice prolamin have been reported. According
to Chen et al. and other investigators [24, 25], human
peripheral blood mononuclear cells (HPBMCs) exposed to
rice prolamin secreted IFN-γ, and the conditioned
medium prepared from HPBMCs cultured in the presence
of rice prolamin inhibited the growth of human leukemia
U937cells and triggered the differentiation of the cells to-
ward monocytes. Because rice prolamin is indigestible
[12, 26], an exception among the rice proteins, dietary
rice prolamin seems to pass through the intestine in
macromolecular forms, where it may induce immune
reactions. Therefore, the above observations suggest
that dietary rice prolamin may be beneficial for AD via
immunomodulatory function.
In the present study, we examined the protective ef-
fects of dietary supplementation of rice prolamin extract
(RPE) on DNCB-induced AD-like lesions in BALB/c
mice. We also examined the effects of dietary RPE on
Th1 and Th2 immunities in the above mice.
Methods
Animals and materials
Six-week-old female BALB/c mice were purchased from
Jungang Lab Animal, Inc. (Seoul, Korea) and were housed
in an air-conditioned room (22 ± 2 °C) with a 12-h dark–
light cycle and were allowed free access to water and food.
2, 4-Dinitrochlorobenzene (DNCB) was purchased from
Sigma-Aldrich Co. (St. Louis, MO, USA) and dissolved in
acetone-olive oil (4:1, v/v). All other reagents used were of
the analytical grade commercially available. This study
was approved by the Institutional Animal Care and Use
Committee of Chonnam National University Medical
School (approval No.: CNU IACUC-H-2015–5).
Preparation and feeding of rice prolamin extract (RPE)
Rice (cultivar Dongjinchal) supplied from Changpyeong
NH (Damyang, Korea) was ground to pass through a
0.18 mm screen (Daehwa Precesion, Cheonan, Korea).
Prolamins were extracted from rice flour with 70 % etha-
nol, as described previously [27] with minor modifica-
tions. Rice flour (100 g) was defatted with hexane and
dried in a fume hood at room temperature for 24 h. The
defatted flour was then extracted by stirring in 400 ml of
5 % NaCl at 20 °C for 4 h and centrifuged at 3,000 × g
for 30 min to remove the albumin and globulin frac-
tions. The residue after extraction of albumin-globulin
was extracted with 300 ml of 70 % ethanol at 20 °C for
4 h to isolate the prolamin fraction. Each extraction step
was repeated twice to remove most of the protein frac-
tion. The prolamin fraction was then dialyzed against
distilled water, lyophilized and then stored at 4 °C. An
aliquot of the freeze-dried extract was dissolved in 70 %
ethanol containing 25 mM NaOH and its protein con-
centration was determined with a BCA protein assay kit
(Thermo Scientific, Rockford, IL, USA) and purified
13 kDa prolamin as the standard. The average total
solids in the prolamin fraction extracted from 100 g rice
flour were 0.53 g and the average protein content of the
solids was 64.5 %. The mice were fed a dietary powder
supplemented with 0, 0.05 % and 0.1 % lyophilized RPE.
The dietary powder was prepared by pulverizing the
standard laboratory chow R03 (SAFE Lab Diets, Augy,
France), and fresh diet was provided daily for 6 weeks
according to the schedule summarized in Fig. 1.
Induction of AD-like lesions
The DNCB patched model described by Lee et al. [28]
was used. The backs of mice were shaved with an elec-
tric clipper and depilatory cream a day before DNCB
sensitization. The DNCB sensitization and challenge
were performed for 2 weeks according to the schedule
summarized in Fig. 1. For the sensitization process, a
1 cm2 gauze-attached patch (Tegaderm®, 3 M Health
Care, St. Paul, MN, USA) was applied with 0.1 ml of 1 %
DNCB and attached to the shaved area for 2 days on day
0 and 3. For the challenge process, the gauze-attached
patch was applied with 0.1 ml of 0.2 % DNCB and at-
tached to the sensitized area for a day on day 7 and 10.
The mice were sacrificed on day 14 to evaluate the ef-
fects of DNCB and RPE treatments.
Assessment of the severity of skin lesions
The severity of DNCB-induced skin lesions was clinically
assessed as previously described [29, 30]. The dermatitis
score was defined as a sum of individual scores (0, no
symptom; 1, mild; 2, moderate; 3, severe) for the following
four signs and symptoms: erythema/hemorrhage, edema,
erosion and dryness.
Fig. 1 Experimental protocol for rice prolamin extract (RPE) feeding and
induction of atopic dermatitis. BALB/c mice were fed diet supplemented
with 0, 0.05 % and 0.1 % RPE for 6 weeks. For the last 2 weeks, the back
skin of mice was applied repeatedly with DNCB to induce AD. For DNCB
sensitization, a 1 cm2 gauze-attached patch was applied with 0.1 ml of
1 % DNCB and attached to the back skin for 2 days on day 0 and 3. And
for the following challenge process, the gauze-attached patch was
applied with 0.1 ml of 0.2 % DNCB and attached to the sensitized area
for a day on day 7 and 10. The mice were sacrificed on day 14 to
evaluate the effects of DNCB and RPE treatments
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Measurement of transepidermal water loss (TEWL)
TEWL was measured under forane anesthesia using a
Tewameter TM300 (Courage and Khazaka Electronic
GmbH, Köln, Germany) in a climate-controlled room.
Histopathological analysis
The dorsal skins of the mice were removed and fixed in
10 % phosphate-buffered formalin. The skin sections
(4 μm thick) were stained with hematoxylin and eosin to
evaluate the epidermal hyperplasia and the other sec-
tions were stained with toluidine blue and Giemsa to
evaluate the infiltration of mast cells and eosinophils.
Measurement of serum immunoglobulins
Blood samples were collected by cardiac puncture under
anesthesia, and sera were collected by centrifugation and
stored at −80 °C until use. The serum IgE, IgG1 and IgG2a
levels were measured with monoclonal antibody pairs by
sandwich ELISA using commercial kits (eBioscience, San
Diego, CA, USA). Briefly, microtiter plates were coated
with monoclonal rat antimouse IgE, IgG1 or IgG2a anti-
body, followed by sequential incubation of serially diluted
purified mouse IgE, IgG1 and IgG2a (standards) or sera
(in triplicate), horseradish peroxidase-conjugated mono-
clonal antimouse IgE, IgG1 or IgG2a antibody, and then
the substrate. The absorbance of the resulting product
was read using a microplate reader (BioTek Instruments,
Inc., Winooski, VT, USA).
Measurement of IL-4 and IFN-γ mRNA expression in the
skin by real-time polymerase chain reaction (RT-PCR)
Total RNA was extracted from skin tissue with the TRIzol
reagent (Invitrogen Life Technologies, Grand Island, NY,
USA) according to the manufacturer’s instruction. The
quantity and purity of total RNA were determined with a
Nanodrop reader (Nanodrop Technologies, Wilmington,
DE, USA). One microgram of total RNA was converted to
the first-strand DNA with Moloney murine leukemia virus
(MMLV) reverse transcriptase (Invitrogen Life Technolo-
gies) and RNAsin (Takara, Otsu, Shiga, Japan). cDNA was
amplified using gene-specific primers and GoTaq®
DNA polymerase (Promega, Madison, WI, USA). Pri-
mer sequences were as follows: IFN-γ, 5′-GTCAA-
CAACCCACAGGTCCA-3′/5′-ACTCCTTTTCCGCT
TCCTGA-3′; IL-4, 5′- CTTCCAAGGTGCTTCGCAT
A-3′/5′-AAGCCCGAAAGAGTCTCTGC-3′; β-Actin,
5′- CTAGGCACCAGGGTGTGATG-3′/5′-GGGGTA
CTTCAGGGTCAGGA-3′. β-Actin was used as the in-
ternal control.
Statistical analysis
The results are presented as mean ± SD. The significance
of differences of all results was analyzed by one-way ana-
lysis of variance (ANOVA) followed by the Scheffe’s test.
Results
Effect of dietary RPE on clinical symptoms of DNCB-
induced dermatitis in BALB/c mice
Following repeated application of DNCB to the back skin
of mice for 2 weeks, AD-like lesions developed. Clinical
symptoms such as erythema/hemorrhage, edema, erosion
and dryness were evident with the average dermatitis
score approaching 10 (Fig. 2). Skin barrier function also
decreased markedly in DNCB-treated mice compared to
the normal group, as evidenced by the increase in TEWL
(Fig. 3). Dietary RPE dose-dependently suppressed the
clinical symptoms of dermatitis and attenuation of skin
barrier function induced by DNCB treatment. It inhibited
the DNCB-induced increase in dermatitis score by 40.7 and
68.4 % at 0.05 and 0.1 %, respectively, and inhibited the
DNCB-induced TEWL increase by 38.2 and 59.7 % at 0.05
and 0.1 %, respectively (Figs. 2 and 3).
Fig. 2 The preventive effect of dietary RPE on AD-like skin lesions induced by DNCB treatment in mice. a Photographs showing skin lesions
(marked with a square) in the different groups of experimental mice: a, normal control; b, DNCB control; c, DNCB + 0.05 % RPE; d, DNCB + 0.1 %
RPE. b The severity of clinical symptoms of the skin lesions was evaluated macroscopically and expressed as the dermatitis score (maximum
score, 12) which was defined as a sum of individual scores (0, no symptom; 1, mild; 2, moderate; 3, severe) for the following four symptoms:
erythema/ hemorrhage, edema, erosion and dryness. **P < 0.01 compared with the normal group, and †P < 0.05, ††P < 0.01 compared with the
DNCB control group (n = 6)
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Histopathological changes in the skin caused by DNCB
and RPE treatments
We examined the histopathological changes in the back
skins of experimental mice (Fig. 4). The skins of the
DNCB-treated group showed markedly epidermal hyper-
plasia as compared to the normal group. Intriguingly,
this hyperplasia was significantly reduced by RPE treat-
ment (Fig. 4a, b). As seen in toluidine blue and Giemsa
stains, the number of mast cells and eosinophils in the
dermis of DNCB-treated mice was markedly increased
as compared to the normal group. In addition, these
DNCB-induced increments of inflammatory cells were
significantly suppressed by RPE treatment (Fig. 4a, c, d).
Changes in the serum concentrations of IgE, IgG1 and
IgG2a caused by DNCB and RPE treatments
Because serum IgE levels are correlated with the severity
of AD and the serum levels of IgE, IgG1 and IgG2a are
associated with Th2 or Th1 immunity [1, 31], we exam-
ined the serum levels of these three Igs in mice to evalu-
ate the effects of DNCB and RPE on systemic Th1 and
Th2 immunities (Table 1). The serum levels of IgE and
IgG1 were markedly increased in the DNCB-treated
group, although the serum IgG2a level was not changed
significantly by this treatment. Dietary RPE influenced
the serum Ig levels differently in DNCB-treated mice. It
dose-dependently reduced the serum levels of IgE and
IgG1, whereas 0.1 % RPE significantly increased the
serum IgG2a level in DNCB-treated mice.
DNCB and RPE treatments change the mRNA expression
of IL-4 and IFN-γ in the skin
To evaluate the effects of DNCB and RPE treatments on
skin Th1 and Th2 immunities, we examined the expression
of IL-4 and IFN-γ mRNAs in the back skins of experimen-
tal mice. As shown in Fig. 5, the IL-4 mRNA expression
was markedly increased by DNCB treatment, whereas, the
IFN-γ mRNA expression was significantly decreased in
DNCB-treated mice as compared to the normal group.
These results are consistent with earlier observations [28].
Dietary RPE reversed these DNCB-induced changes in Th1
and Th2 cytokine mRNA expressions. That is, RPE treat-
ment suppressed the DNCB-induced increase of IL-4
mRNA expression (Fig. 5a), whereas it increased the IFN-γ
mRNA expression up to more than twice the level of the
DNCB control group (Fig. 5b).
Discussion
This study showed that dietary RPE supplementation
inhibited the AD-like pathology induced by DNCB treat-
ment in BALB/c mice. RPE treatment suppressed not
only the clinical symptoms of dermatitis such as ery-
thema, edema, erosion and dryness (Fig. 2), but also its
histopathological changes such as epidermal hyperplasia
and infiltration of mast cells and eosinophils in the der-
mis (Fig. 4). In addition, RPE treatment suppressed the
DNCB-induced attenuation of skin barrier function, as
evidenced by the changes in TEWL (Fig. 3). The im-
mune cells infiltrated in the skin tissue, following anti-
gen binding, become activated and secrete a variety of
bioactive chemical mediators including histamine, prote-
ases, eicosanoids, cytokines and chemokines, and proin-
flammatory proteins [32]. Bioactive mediators can cause
locally and systemically diverse symptoms and signs in-
cluding those observed in Figs. 2, 3, and 4 [32]. There-
fore, our results indicate that dietary RPE may effectively
prevent AD symptoms.
As shown in Table 1, dietary RPE reduced the serum
levels of IgE and IgG1, whereas it raised the serum
IgG2a level, in DNCB-treated mice. It is known that
IFN-γ stimulates the expression of IgG2a and inhibits
the production of IgE and IgG1. In contrast, IL-4 has
powerful effect in stimulating the expression of IgE and
IgG1 but markedly inhibits the expression of IgG2a [31].
Although the mechanism for the anti-AD action of RPE
remains unclear, the results of Table 1 strongly suggest
that upregulation of Th1 immunity and downregulation
of Th2 immunity are a principal mechanism for the RPE
action. Indeed, we found that RPE treatment suppressed
IL-4 mRNA expression and raised IFN-γ mRNA expres-
sion in the skin of DNCB-treated mice (Fig. 5), support-
ing the above suggestion that upregulation of Th1
immunity and downregulation of Th2 immunity are in-
volved in the anti-AD action mechanism of dietary RPE.
Because Th2 cytokine production is a default pathway in
many systems [33–35] and Th1 and Th2 expressions are
antagonistic to each other, it follows that upregulation of
IFN-γ expression by RPE may be the primary causative
Fig. 3 The preventive effect of dietary RPE on DNCB-induced
attenuation of skin barrier function in mice, based on transepidemal
water loss (TEWL). TEWL was measured using a Tewameter TM300 in a
climate-controlled room. **P< 0.01 compared with the normal group,
and †P< 0.05, ††P< 0.01 compared with the DNCB control group (n= 6)
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factor that leads to downregulation of Th2 expression
and other RPE effects observed in this study. For ex-
ample, IFN-γ can seriously influence Th1/Th2 cell differ-
entiation and cytokine production [36]. IFN-γ activates
signal transducer and activator of transcription 1 (Stat1),
which upregulates the leading Th1 transcription factor,
T-bet, further enhancing Th1 cytokine production. Con-
currently, IFN-γ inhibits Th2 cytokine production by
interfering with GATA, a Th2 transcription factor. Fur-
thermore, inflammatory cells in local skin lesions are re-
cruited by complex interactions of chemokines and
chemokine receptors whose expression is also regulated
by Th1 and Th2 cytokines [32, 37]. IFN-γ amplifies Th1
responses by inducing Th1-type chemokines and their
receptors and by preventing the expression of Th2-type
receptor ligands. AD is characterized by hyperactivated
Th2 cytokines that lead to immunoglobulinemia E, eosino-
philia, epidermal thickening and other AD-associated in-
flammatory changes [4, 5]. These Th2 immune responses,
however, can be suppressed by IFN-γ [6]. The formation
and maintenance of skin barrier are also influenced by Th1
Fig. 4 Histopathological findings showing the preventive effect of dietary RPE on DNCB-induced AD-like skin lesions in mice. a Skin sections
(4 μm thick) were stained with hematoxylin & eosin (upper panel), toluidine blue (middle panel) and Giemsa (lower panel). ED, epidermis; Dr,
dermis; magnification, 200 ×; scale bars, 50 μm. b Epidermal thickness was analyzed in the hematoxylin & eosin-stained sections. c The number of
mast cells was analyzed in the toluidine blue-stained sections. d The number of eosinophils was analyzed in the Giemsa-stained sections.
**P < 0.01 compared with the normal group, and †P < 0.05, ††P < 0.01 compared with the DNCB control group (n = 6)
Table 1 Effects of dietary RPE on serum levels of lgE, lgG1 and
lgG2a in DNCB-treated mice
Treatment lgE (ng/ml) lgG1 (mg/ml) lgG2a (mg/ml)
Normal 42.7 ± 14.6 0.334 ± 0.041 0.102 ± 0.019
DNCB 264.0 ± 38.5** 2.326 ± 0.411** 0.110 ± 0.013
DNCB + 0.05 % RPE 175.0 ± 26.9†† 1.648 ± 0.274†† 0.124 ± 0.024
DNCB + 0.1 % RPE 148.7 ± 25.4†† 1.388 ± 0.216†† 0.159 ± 0.016†
The serum lg levels were determined by ELISA. **P <0.01 compared with the
normal group, and † P <0.05, †† P <0.01 compared with the DNCB control
group (n = 6)
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and Th2 cytokines [38]. IFN-γ stimulates ceramide
synthesis through the action of enzymes, sphingomye-
linase and glucocebrosidase, resulting in suppression
of TEWL [38, 39]. And IFN-γ may play a role in main-
taining the skin barrier by regulating Th2 cytokine re-
ceptors, because Th2 cytokines inhibit the formation of
skin barrier [38]. Thus, IFN-γ can modify all the
DNCB-induced AD-like changes observed in this
study: clinical symptoms, attenuation of skin barrier
function, immune cell infiltration, and changes in
serum IgE, IgG1 and IgG2a levels and skin Th1 and
Th2 cytokine mRNA expressions.
Although earlier studies showed that PBMCs exposed
to rice prolamin secreted IFN-γ in vitro [27, 28], it is un-
certain how dietary RPE can activate Th1 responses in
vivo. As dendritic cells are the only antigen presenting
cells known to sample luminal contents from the intestine
[35, 40], they play a critical role in Th1 cell activation by
commensal bacteria- and food-associated antigens [35].
They sample and uptake antigens from the gastrointestinal
luminal compartment and processed the antigens [40–42].
After migrating to nearby lymph nodes, they present the
processed antigens to T cells and stimulate T cell differen-
tiation. They also secrete IL-12, which binds to the IL-12
receptor on T cells and signals to activate Th1 cell differ-
entiation [36]. The differentiated Th1 cells can then mi-
grate to extraintestinal sites [35]. It will be an important
task to find out whether dietary RPE acts in a similar way
to the above mentioned antigens or if it acts by other
mechanisms.
In the present study, dietary RPE significantly pre-
vented the AD-like symptoms induced by DNCB treat-
ment in mice and it improved the Th1/Th2 balance that
was skewed to Th2 by DNCB treatment. Because rice is
a common, stable and safe food, RPE can be a potential
resource for the development of new therapeutic agents
for AD. Further studies including clinical researches are
required to prove this possibility.
Conclusions
This study indicated that dietary RPE was protective
against DNCB-induced AD-like lesions in BALB/c mice.
Our results suggest that dietary RPE exerts its anti-AD
effect via upregulation of Th1 immunity and that RPE
may be useful for the treatment of AD.
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